Loading...

Loading...

AI's Path to Personalized Medicine: Pharma's Breakthrough Journey
By Sandra Sánchez-Oldenhage - Thu, 03/07/2024 - 12:00
Embracing AI can help pharma companies unlock opportunities, redefine norms, and shape the future of healthcare, writes Sandra Sánchez-Oldenhage.
https://mexicobusiness.news/tag/sandra-sanchez-oldenhage
More Health
 Loneliness, AMR, Pharma Distribution: This Week in Health
By Anmol Motwani - Thu, 11/23/2023 - 09:32

The WHO addresses the global loneliness crisis, AMR Awareness Week combats drug resistance, and the pharma industry charts faces profit challenges.

Charting Profitable Waters: The Revolution of Pharma Distribution
By Sandra Sánchez-Oldenhage - Thu, 11/16/2023 - 12:00
Amid distribution tempest, innovative strategies can help pharma set sail toward a resilient and prosperous future, writes Sandra Sánchez-Oldenhage.
Apple's iPhone 15 Launch: India's Milestone and Mexico’s Role
By Anmol Motwani - Tue, 09/12/2023 - 11:19
The launch with Made-in-India iPhone models signals Apple's commitment to India and opens doors for global supplier collaboration, including Mexico.

Innovation or Inaccessibility: The Dilemma of Modern Medicine
By Sandra Sánchez-Oldenhage - Tue, 05/23/2023 - 17:00
In a world where affordable and innovative medical treatments remain a luxury, it’s time for a holistic approach. Sandra Sánchez-Oldenhage explains.
Nearshoring in Mexico: The Healthcare and Pharma Opportunity
By Sandra Sánchez-Oldenhage - Thu, 03/09/2023 - 08:45
Mexico can be a formidable alternative to China for pharma manufacturers — if it can manage its drawbacks, writes Sandra Sánchez-Oldenhage.
Pharma Omnichannel: An Enhanced Personalized Customer Experience
By Sandra Sánchez-Oldenhage - Thu, 12/01/2022 - 11:00
Without an omnichannel mindset, you may be missing out on crucial opportunities to improve brand experience, writes Sandra Sanchez-Oldenhage.
Pharmacoeconomics: Tool for Innovation and Access
By Sofía Garduño - Wed, 08/31/2022 - 16:32
Healthcare providers are embracing pharmacoeconomics to make better decisions, but the field must also improve.

ESG for Pharma: Fad or Megatrend?
By Sandra Sánchez-Oldenhage - Fri, 08/26/2022 - 09:00
ESG is a business fundamental and should not be viewed as a mandatory requirement or the right thing to do, writes Sandra Sánchez-Oldenhage.
The Pharma E-Commerce Opportunity: What It Takes to Win
By Sandra Sánchez-Oldenhage - Fri, 05/20/2022 - 09:00
Optimizing the pharma business model by offering e-commerce options in this digital era is simply smart business, writes Sandra Sánchez-Oldenhage.